Koers Bone Biologics Corporation Other OTC
Aandelen
BBLG
US0980702049
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 1,35 mln. 1,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,48 mln. | Nettowinst (verlies) 2025 * | -8 mln. -7,48 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,05
x | K/w-verhouding 2025 * |
-0,05
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Frelick
CEO | Chief Executive Officer | 59 | 17-08-15 |
Deina Walsh
DFI | Director of Finance/CFO | 60 | 01-11-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Stroever
BRD | Director/Board Member | 75 | 01-01-12 |
Don Hankey
CHM | Chairman | 81 | 16-07-18 |
Robert Gagnon
BRD | Director/Board Member | 49 | 08/01 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,07% | 128 mld. | |
-9,04% | 10,65 mld. | |
+0,91% | 8,82 mld. | |
+16,72% | 7,19 mld. | |
+25,15% | 4,99 mld. | |
+7,17% | 3,4 mld. | |
-1,36% | 3,03 mld. | |
-8,73% | 2,14 mld. | |
-10,15% | 2 mld. |